What is the price target for CSTM stock?
10 analysts have analysed CSTM and the average price target is 29.92 USD. This implies a price decrease of -4.65% is expected in the next year compared to the current price of 31.38.
NYSE:CSTM • FR0013467479
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CONSTELLIUM SE (CSTM).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-16 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-04-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-19 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-02-19 | Deutsche Bank | Maintains | Buy -> Buy |
| 2026-02-19 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-13 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-10-30 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-30 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-08 | Wells Fargo | Initiate | Equal-Weight |
| 2024-10-24 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-10-24 | Deutsche Bank | Downgrade | Buy -> Hold |
| 2024-10-11 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-10-10 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-10-03 | Deutsche Bank | Maintains | Buy -> Buy |
| 2024-07-24 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-07-16 | Deutsche Bank | Maintains | Buy -> Buy |
| 2024-07-11 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-04-25 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-04-19 | Benchmark | Reiterate | Buy -> Buy |
| 2024-04-10 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-01-23 | Deutsche Bank | Maintains | Buy -> Buy |
| 2024-01-16 | UBS | Initiate | Buy |
| 2023-12-04 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-07-27 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.826B -3.62% | 7.335B -6.27% | 8.449B 15.19% | 10.262B 21.46% | 10.313B 0.50% | |
| EBITDA YoY % growth | 730M 15.32% | 575M -21.23% | 800M 39.13% | 839.33M 4.92% | 886.24M 5.59% | |
| EBIT YoY % growth | 430M 24.28% | 271M -36.98% | 470M 73.43% | 513.47M 9.25% | 557.98M 8.67% | |
| Operating Margin | 5.49% | 3.69% | 5.56% | 5.00% | 5.41% | |
| EPS YoY % growth | 0.92 -57.71% | 0.45 -51.20% | 1.66 269.22% | 2.05 23.61% | 2.40 16.73% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.62 139.34% | 0.58 130.87% | 0.45 29.01% | 0.45 -44.31% | 0.62 | 0.63 8.82% | 0.61 34.59% | 0.57 27.48% |
| Revenue Q2Q % growth | 2.587B 37.58% | 2.533B 36.55% | 2.388B 10.25% | 2.351B 6.82% | 2.385B -7.81% | 2.439B -3.71% | 2.396B 0.34% | 2.371B 0.85% |
| EBITDA Q2Q % growth | 231.31M 35.27% | 223.64M -6.82% | 197.68M -47.14% | 189.64M -61.84% | 220.39M -4.72% | 225.62M 0.89% | 223.65M 13.14% | 217.6M 14.74% |
| EBIT Q2Q % growth | 148.17M 59.32% | 138.11M 72.64% | 115.53M -11.13% | 109.34M -34.53% | 136.48M -7.89% | 141.47M 2.43% | 138.67M 20.03% | 132.35M 21.04% |
All data in USD
10 analysts have analysed CSTM and the average price target is 29.92 USD. This implies a price decrease of -4.65% is expected in the next year compared to the current price of 31.38.
CONSTELLIUM SE (CSTM) will report earnings on 2026-04-29, before the market open.
The consensus EPS estimate for the next earnings of CONSTELLIUM SE (CSTM) is 0.62 USD and the consensus revenue estimate is 2.59B USD.